| HOME >> BIOLOGY >> TECHNOLOGY |
Unearned revenue and contract advances 1,937,451 2,263,091
Shareholders' equity:
Share capital:
Common shares 28,644,454 28,644,454
Warrants 9,603,644 9,603,644
Compensation warrants 912,377 912,377
Contributed surplus 2,210,993 1,510,176
Deficit (29,581,295) (21,476,594)
-----------------------------------------------------------------------
11,790,173 19,194,057
Guarantees
Commitments
-------------------------------------------------------------------------
17,492,767 23,209,513
-------------------------------------------------------------------------
-------------------------------------------------------------------------
ARIUS RESEARCH INC.
(a Development Stage Company)
INTERIM STATEMENTS OF OPERATIONS, COMPREHENSIVE LOSS AND DEFICIT
(Unaudited)
------------------------------------------------------------
Nine-month Nine-month
period ended period ended
August 31, August 31,
2007 2006
$ $
------------------------------------------------------------
Revenue:
Research Contract 508,660 -
Product 98,942 -
Licensing fees 165,012 2,592,041
Research grant payments 73,360 75,969
----------------------------------------------------
'/>"/>
| SOURCE ARIUS Research Inc. Copyright©2007 PR Newswire. All rights reserved |